Optibrium, Molecular Networks to Share Tech Platforms | GenomeWeb

NEW YORK (GenomeWeb News) – Optibrium and Molecular Networks today said that they will share complementary technology platforms for the drug discovery market.

The collaboration will integrate Molecular Networks' 3D structure generator, Corina, into Optibrium's StarDrop, a platform for guiding compound selection and design.

According to the firms, Corina is used within StarDrop's predictive P450 metabolism models, which identify metabolic liabilities of candidate molecules against the major cytochrome P450 enzymes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.